New markers could improve treatment and survival in acute lymphoblastic leukemia
Friday, December 21, 2012 - 10:30
in Health & Medicine
Acute lymphoblastic leukemia, the most common pediatric cancer, has been the subject of a new study. Newly identified genetic markers could improve the classification of risk groups and predict treatment toxicity in the patient.